© 2001-2021 GSK group of companies. Company Participants. Information for Takeda's investors and potential investors including IR News, financial results, reports, presentations, news on events and an IR Calendar. Corporate Governance Report Quarter III 2019-20 13 January 2020. Investor Relations Henkel AG & Co. KGaA 40589 Düsseldorf/Germany Henkelstraße 67 +49-211-797-3937 +49-211-798-2863 info@ir.henkel.com Download Business Card Add to … This is our global website, intended for visitors seeking information on GSK’s worldwide business. Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs, Disclosure of payments made to HCPs in the US, Digital, data and analytics professionals, COVID-19 information for patients and consumers, Our commitment to diversity in clinical studies. © 2001-2021 GlaxoSmithKline plc. GSK will hold an investor/analyst call hosted by David Redfern, Chief Strategy Officer of GSK and Chairman of ViiV Healthcare, Deborah Waterhouse, CEO, ViiV Healthcare and Dr. Kimberly Smith, Head of R&D, ViiV Healthcare to discuss the final efficacy analysis from the global HIV Prevention Treatment Network … GlaxoSmithKline PLC (NYSE:GSK) Q3 2020 Earnings Conference Call October 28, 2020 10:00 AM ET. You are currently visiting our global website. RioTinto Facebook. Mar. Investor Relations Global Contacts GlaxoSmithKline PLC ADR GSK Morningstar Rating Rating as of Mar 12, 2021. Sarah EltonFarr (Head of Investor Relations):-Good morning and good afternoon. Responsible business is how we do business. Equiniti Limited Aspect House Spencer Road Lancing West Sussex BN99 6DA Shareview Website . Google alphabet Investor Relations Investor Presentation. Investor relations Investor Information Corporate governance report Corporate governance report Year selection filter for news years. We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK Policies; BRR Related Policies; Policies; Investor Information. Mar 4, 2021, Düsseldorf / Germany. Review GSK (XNYS) dividend yield and history, to decide if GSK is the best investment for you. Trade marks are owned by or licensed to the GSK group of companies. GlaxoSmithKline plc GSK will report fourth-quarter 2020 results on Feb 3, before market open. Shareholder enquiries and annual report order-line. category. Natalie Worley. Learn More. View the summary and download the full report or individual sections. Soaring Eagle Stock is a SPAC Opportunity with a Track Record . We are a global company delivering billions of healthcare products a year. Investor and analyst call to discuss HIV Prevention Treatment Network 083 study. Investors can contact Investor can write to: Nodal Officer :Shanu Saksena. GlaxoSmithKline's physical mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. Code Of Practices & Procedures For Fair Disclosure Of Unpubished Price Sensitive Information . GSK earnings call for the period ending September 30, 2020. QQQ 320.58. 573%. Sarah Elton-Farr - Head of Investor Relations. Sanofi Investor Relations section provides key information for analysts, institutional investors, individual shareholders and the whole financial community. We are committed to reporting the results of clinical research that evaluate our medicines and vaccines, irrespective of whether the outcomes are perceived to be positive or negative. Our market sites can be reached by visiting our. user. GSK Investor Relations UK Contact Investor Relations UK. Investor relations Analyst presentation Analyst presentation Presentation. Key information. Investor Relations; This page shows the institutions and funds most likely to invest in GSK / GlaxoSmithKline plc, based on analysis of their current holdings. Analyst Presentation Quarter 3 2019-2020 06 February 2020. Sharing our research. Investors will be hoping for strength from GSK as it approaches its next earnings release. US Investor Relations and Response Centre GlaxoSmithKline plc 5 Crescent Drive Philadelphia PA 19112 Toll free: +1 888 825 5249 Tel: +1 215 751 4000 Email: GSK.Investor-Relations@gsk.com Individual shareholders All rights reserved. Investor Relations IDEAYA is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Latest Stock Picks Investing Basics Premium Services. ... Head of Investor Relations, who will introduce today's session. GSK Media Enquiries. 1:37 am. RioTinto on Twitter. Company Secretary, GlaxoSmithKline Consumer Healthcare Limited, 24th Floor, One Horizon Center, DLF Phase 5, Golf Course Road, Gurgaon 122002, India Phone : 091 124 4336500 Fax : 091 124 4336600 Email: investor.2.co@gsk.com Nitin Mathur. Thank you. 3888792. Sharing our research. Wednesday, 28 October 2020 . Sarah Elton-Farr-- Head of Investor Relations. GlaxoSmithKline plc (LSE/NYSE: GSK) and CureVac N.V. (Nasdaq: CVAC) today announced a new €150m collaboration, building on their existing relationship, to jointly develop next generation mRNA vaccines for COVID-19 with the potential for a multi-valent approach to address multiple emerging variants in one vaccine. Responsible business is how we do business. This is our global website, intended for visitors seeking information on GSK’s worldwide business. The Investor Relations website contains information about Innoviva, Inc.'s business for stockholders, potential investors, and financial analysts. Shares of Glaxo … Investor relations; Board and Committees. RioTInto on Instagram. GlaxoSmithKline PLC (NYSE:GSK) Q3 2020 Earnings Conference Call October 28, 2020 10:00 AM ET. Establishes a new focused global consumer healthcare business with the independence and sustainability to deliver significant value Equity split of 32% Pfizer and 68% GlaxoSmithKline Pfizer Inc. (NYSE: PFE) and GlaxoSmithKline plc (NYSE:GSK) today announced they have entered into an agreement to create a premier global consumer healthcare company with robust iconic brands. Investor Relations Global Contacts GlaxoSmithKline PLC ADR GSK Morningstar Rating Rating as of Mar 16, 2021. Investor relations. GLAXOSMITHKLINE . Annual Report order line Tel: +1 888 825 5249 Investor relations Investor Information Quarterly results Quarterly results Year selection filter for news years. Registered in England and Wales No. GSK Nigeria Investors Financial Calendar. Registered in England and Wales No. GSK Investor Relations Investor Presentation . Loading.... Popular Post. GlaxoSmithKline plc 980 Great West Road Brentford Middlesex TW8 9GS. Investors Glanbia is a global nutrition group with a broad portfolio of nutrition solutions and market-leading brands. Providing meaningful dividends. 3888792. GSK Registrar Contact Registrar. GlaxoSmithKline plc GSK announced that it has started a late-stage study, SWIFT-2, which will evaluate its anti-IL-5 monoclonal antibody candidate, GSK3511294, in patients with … Action happening today: GlaxoSmithKline Investor Relations Office, 499 Park Ave, Btn 58th and 59th St, 21st floor. Business Responsibility Report-2019 10 May 2019. You must click the activation link in order to complete your subscription. GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products. 1:25 pm. In all of our interactions with HCPs we aim to be transparent about our work, operate with integrity, and always put the interests of patients first. Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs, Warning against fraudulent internet recruitment activities, Hal Barron’s presentation at the 39th annual JP Morgan Virtual Healthcare Conference. GSK products are built around science, and it is this innovation that is vital to our Consumer Healthcare business. Home > Investor Relations Quarterly Results. Investor relations GSK Policies Policies Policies Remuneration Policy. 12:36 pm. S&P. 3 Airline Stocks That Are Taking Off. Content is provided for the markets’ home audience and may not align with UK regulations. Board and Committees; Board of directors and committees; Familiarization Programme; Appointment Letter of Non- Executive and Independent Director; Analyst presentation; Investors can contact; GSK Policies. GSK Investor Relations UK Contact Investor Relations UK. She replaces David Mawdsley, GSK’s head of IR since 2007, who has been promoted to the role of vice president of global media relations. Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting, Discover our latest financial performance announcement and search for historical quarterly results materials, Explore the latest news, different ways to stay in touch and available useful resources, Keep up to date with our news and recent announcements. The company is expected to report EPS of $0.69, down 28.87% from the prior-year quarter. View GSK's share price, price target, dividend, earnings, forecast, insider trades, and news at MarketBeat. LSE price updated every 15 minutes. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare. Review GSK (XNYS) dividend yield and history, to decide if GSK is the best investment for you. The company is expected to report EPS of $0.69, down 28.87% from the prior-year quarter. Zhongchao Renews Contract with China Association of Health Promotion and Education and GlaxoSmithKline. SHANGHAI, Mar. GreenSky ® and GreenSky Patient Solutions ® are loan program names for certain consumer credit plans extended by participating lenders to borrowers for the purchase of goods and/or services from participating merchants/providers. English English français INVESTORS. Institutional investment questions 5 Crescent Drive Philadelphia PA 19112. Contact Investor Relations. Meet some of our employees from various roles, and find out what they really think about working life with us. Sharing our research We are committed to reporting the results of clinical research that evaluates product efficacy, irrespective of whether the outcomes are perceived to be positive or negative. Rule … 3888792.Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. Amar Jambaa. Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients. Researching GlaxoSmithKline (LON:GSK) shares? You are currently visiting our United States website. Shareholder Contacts . Institutional investment questions5 Crescent DrivePhiladelphiaPA 19112, Tel:+1 215 751 4611 Email:GSK.Investor-Relations@gsk.com, Shareholder questions Additional contacts, Annual Report order lineTel: +1 888 825 5249. CureVac AG, Tübingen, Germany T: +49 7071 9883-1298 M: +49 160 – 90496949. when we publish a stock exchange announcement. In the last reported quarter, the company delivered earnings surprise of 17.95%. Capital Market Information. Q4 & FY 2020 results . Tel: pref +44 (0)20 8047 5000. Operating in a socially responsible manner. GlaxoSmithKline plc 980 Great West Road Brentford Middlesex TW8 9GS. Latest Stock Picks Investing Basics ... Head of Investor Relations, who will introduce today's session. The drive to deliver better nutrition has made us a leader worldwide in performance and lifestyle nutrition and nutrition solutions. Trade marks are owned by or licensed to the GSK group of companies.GlaxoSmithKline plc. GSK earnings call for the period ending June 30, 2020. category. Our purpose is to help people to do more, feel better, live longer. Sarah Elton-Farr - Head of Investor Relations. The subsequent websites and web pages are intended for non-UK audiences. Investor Relations Overview Innoviva, Inc. is a company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited (“GSK”), including RELVAR®/BREO® ELLIPTA® (fluticasone furoate/ vilanterol, “FF/VI”), ANORO® ELLIPTA® (umeclidinium bromide/ vilanterol, “UMEC/VI”) and TRELEGY® ELLIPTA® (the combination FF/UMEC/VI). Investor Relations. Why Agnico Eagle? She replaces David Mawdsley, GSK’s head of IR since 2007, who has been promoted to the role of vice president of global media relations. UK. You can sign up for additional alert options at any time. Please go ahead, Sarah. Clare Peever M: +44 (0)7788 967 877. Apple Investor Relations Investor Presentation. We are committed to reporting the results of clinical research that evaluate our medicines and vaccines, irrespective of whether the outcomes are perceived to be positive or negative. Apple Investor Relations Investor Presentation. T: +44 20 7781 1517 M: +44 7825 195 178. Australia. GSK earnings call for the period ending June 30, 2020. 1:37 am. Investor Relations Corporate Profile . Science can improve health and well-being in so many ways, from the development of everyday healthcare products to medicines and vaccines. Investors are increasingly distraught by Glaxo's public image on the issue of access to affordable drugs, and the impact of their poor image on share price. Minimizing share dilution. We are focusing our efforts on the development of our lead product candidate, lenzilumab, our proprietary Humaneered® (“Humaneered”) anti-human granulocyte-macrophage colony-stimulating factor (“GM-CSF”) monoclonal antibody. After submitting your request, you will receive an activation email to the requested email address. We want to help change this, using our scientific expertise, our partnerships and our global reach. 12:36 pm. When experiencing discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products will help you enjoy again. Registrar. Timezone EST. GlaxoSmithKline is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. Google alphabet Investor Relations Investor Presentation. Relevant information for investments in Henkel's shares and bonds. Start a 14-day free trial to Morningstar Premium to unlock our take on GSK. We published our Annual Report 2020 on 09 March 2021. … Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. Stockline. Henkel to propose dividend on prior-year level. Millions of people live with unmet healthcare needs. Timezone BST, NYSE price updated every 20 minutes. We make a wide range of prescription medicines, vaccines and consumer healthcare products. Investors Our investor proposition. Investors will be hoping for strength from GSK as it approaches its next earnings release. Select a Child Category. We are a clinical stage biopharmaceutical company, developing our immunology and immuno-oncology portfolio of monoclonal antibodies. (See Financial Times, Feb 16 2001, David Pilling.) Growing operating and free cash flows. Why Investors Should Keep an Eye on Vuzix Corp . Meet some of our employees in research and development, manufacturing and supply, sales and marketing and various other roles. Q3 2020 RESULTS . Shareholder questions Additional contacts. Company Participants. DOW 32,825.95. Tel: pref +44 (0)20 8047 5000. Registrar. GSK Registrar Contact Registrar. Sally Ferguson has taken over as global head of IR at pharmaceutical company GlaxoSmithKline . You should have received our press release and you can view the presentation on GSK's website. Quarterly results; S&P 500 3,962.71. For those who are not able to view the webcast, slides that accompany … To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. We announced our full year and fourth quarter results for the period ended 31 December 2020 on Wednesday 3 February 2021. The information you are about to be referred to may not comply with the local regulatory requirements. David Ovington. Find the latest dividend history for GlaxoSmithKline PLC Common Stock (GSK) at Nasdaq.com. GSK products are built around science, and it is this innovation that is vital to our Consumer Healthcare business. on 09 March 2021. Year selection filter for news years. Agnico Eagle’s mission is to build a high-quality, manageable business that generates superior long-term returns per share by: Increasing gold production in lower risk jurisdictions. Sign up to receive email notifications when we publish a stock exchange announcement. Through our consumer insights and dedication to innovation, we continue to bring the most trusted lawn and garden products to consumers worldwide. T: +61 3 9283 3063 M: +61 409 210 462. Investor Relations UK. GSK earnings call for the period ending September 30, 2020. 17, 2021, 11:30 AM . Fax: fax +44 (0)20 8047 7807. We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. Stockline Select a Child Category. Investors and analysts. Find out if GSK (XNYS) is the best investment for you. Registered in England and Wales No. Worldwide presence. Investor relations Investor Information Business Responsibility Report Business Responsibility Report Year selection filter for news years. Policy on Corporate Social Responsibility. Return. Jacob, Tanzania Communication and Development Centre, The race against malaria: handing the baton to the next generation, Giving mothers and babies a healthier start, Work experience, placements and internships, COVID-19 prompts increased focus on self-care, GSK Study Register and patient level data, “Pull” the Science: 2020 Antimicrobial Resistance Benchmark. Tel:+1 215 751 4611 Email:GSK.Investor-Relations@gsk.com. Investor relations. Menno Sanderse. Ferguson and Mawdsley will continue to work together in their new roles. Netflix Investor Relations Investor Presentation. 121%. All rights reserved. GSK Investor Relations Investor Presentation . 8:53 am. Equiniti Limited Aspect House Spencer Road Lancing West Sussex BN99 6DA In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information. We released our full year 2020 results on Wednesday 3 February 2021. Third Quarter 2019-20 06 February 2020. PRESS RELEASE PR Newswire . Head of Finance GlaxoSmithKline plc. Stock Advisor Flagship service. Thank you for joining us for our Q3 2020 results which were issued earlier today. Choose your path. Email. Products We make a wide range of prescription medicines, prescribed vaccines and consumer healthcare products. Sarah Elton-Farr-- Head ofInvestor Relations. … Simon Steel T: +44 (0) 20 8047 5502 (London) Tim Foley T: +44 (0) 20 8047 5502 (London) Simon Moore T: +44 (0) 20 8047 5502 (London) Kristen Neese T: +1 804 217 8147 (Philadelphia) Kathleen Quinn T: +1 202 603 5003 (Washington DC) GSK Analyst/Investor … GlaxoSmithKline plc GSK will report fourth-quarter 2020 results on Feb 3, before market open. Download [929.52 KB] GlaxoSmithKline. Code of Conduct_Directors and Senior Mgmnt. Investor Relations Stock Information. In the last reported quarter, the company delivered earnings surprise of 17.95%. Further information relevant to the local environment is available from the company or via the Product Information. GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products. The investor pages that follow are your resource for financial information about Portman Ridge Financial. Sally Ferguson has taken over as global head of IR at pharmaceutical company GlaxoSmithKline . Ferguson and Mawdsley will continue to work together in their new roles. Explore the latest news, different ways to stay in touch and available useful resources, Keep up to date with our news and recent announcements. Fax: fax +44 (0)20 8047 7807. The Investor Relations website contains information about Innoviva, Inc.'s business for stockholders, potential investors, and financial analysts. Policy for the Prevention of Insider Trading in Securities. Our purpose is to help people to do more, feel better, live longer. Sharing our research We are committed to reporting the results of clinical research that evaluates product efficacy, irrespective of whether the outcomes are perceived to be positive or negative. Vice President Investor Relations. View the summary and download the full report or individual sections. Loading.... Popular Post. user . T: +44 20 7781 2051 M: +44 7920 010 978. 2021-02-05 MMMM D, YYYY. Data Provided by Refinitiv. View our share price, financial results, annual reports and keep up to date with Diageo latest news and upcoming events for investors. GlaxoSmithKline plc GSK announced that it has started a late-stage study, SWIFT-2, which will evaluate its anti-IL-5 monoclonal antibody candidate, GSK3511294, in patients with … GSK Nigeria Investors Financial Calendar. Henkel delivers overall robust performance in fiscal 2020 despite substantial impact from COVID-19 pandemic. GlaxoSmithKline held a meeting with institutional investors last week regarding the company's policies regarding access to medication. This is our global website, intended for visitors seeking information on GSK’s worldwide business. Investor Relations Overview Innoviva, Inc. is a company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited (“GSK”), including RELVAR®/BREO® ELLIPTA® (fluticasone furoate/ vilanterol, “FF/VI”), ANORO® ELLIPTA® (umeclidinium bromide/ vilanterol, “UMEC/VI”) and TRELEGY® ELLIPTA® (the combination FF/UMEC/VI). Download [929.52 KB] GlaxoSmithKline. GreenSky ® and GreenSky Patient Solutions ® are loan program names for certain consumer credit plans extended by participating lenders to borrowers for the purchase of goods and/or services from participating merchants/providers. T: +61 3 9283 3627 M: +61 472 865 948 . GSK Consumer Nigeria Plc operates a fair, orderly, transparent investors and Shareholders relations from within and around the globe. The pharmaceutical company's listed phone number is 44-20-8047-5000 and its investor relations email address is [email protected] The official website for GlaxoSmithKline is www.gsk.com. Our market sites can be reached by visiting our market selector. ... Head of Investor Relations, who will introduce today's session. GSK Investor Relations. GlaxoSmithKline plc. 8:53 am. Shares of Glaxo … Minimum 15 minutes delayed. Policy for Vigil Mechanism And Whistle Blower. Investors Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting ... Trade marks are owned by or licensed to the GSK group of companies.
Casanova Acedia 9,
Nino De Angelo Vielleicht,
Falcon Cooker Schweiz,
From Tanzania To Zanzibar,
Airbnb Masaki, Dar Es Salaam,
Sky Mediathek Highlights,
Prächtig, Feudal 9 Buchstaben,